After pre-announcing that its full-year revenue would come in below its original guidance, Eli Lilly (NYSE: LLY) announced ...

Eli Lilly and Company (NYSE: LLY) is one of two pharmaceutical stocks behind the weight loss drug craze that has impacted the ...

We came across a bullish thesis on Eli Lilly and Company (LLY) on Substack by Kontra Investments. In this article, we will ...

So far in 2025, the year’s biggest cultural events have served as launchpads for several of the industry's latest cancer ...

That’s why one of the most closely watched elements of a company ... Here are three stocks from companies that missed on earnings but have strong support from analysts. Eli Lilly & Co. (NYSE: LLY) ...

For years, people taking Ozempic or other drugs in the same class for diabetes and weight loss have noticed the medicines don't just curb their desire to eat; for some, they also lead them to drink ...

Immunotherapy, which uses programmed immune cells to selectively destroy cancer cells, has transformed cancer treatment.

An international clinical trial aimed at preventing Alzheimer’s disease (AD) in young adults who are at risk of developing ...

Andy Reid is a three-time Super Bowl champion, potentially looking to add some more hardware to the mantle to conclude this ...

This innovative program addresses global health initiatives and medical training in Peru with Partners in Health, known ...

Healthcare stocks have something to offer every investor. If you're looking for high growth, you can try an innovative ...